Interplay between psychosocial and heart failure related factors may partially explain limitations in self-efficacy in patients with heart failure: Insights from a real-world cohort of 1,123 patients

Calero-Molina, E; Moliner-Borja, Pedro; Hidalgo, E; Rosenfeld, L; Verdú-Rotellar, José María; Soriano, José Verdú; Yun, Sergi; Garay, Alberto; Alcoberro, L; Jiménez-Marrero, Santiago; Jose, N; Calvo, Elena; Ruiz, Marta Mesalles; Garcimartín, Paloma; Alcaide-Aldeano, Alex; Delso, C; Alcober, Laia; Enjuanes, Cristina; Comín‐Colet, Josep

doi:10.1016/j.ijnurstu.2022.104233

Cited by 4 publications

(2 citation statements)

References 37 publications

(65 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Inclusion and exclusion criteria . The methodology of the DAMOCLES study was previously published by our group [ 13 , 14 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 ]. Briefly, for inclusion, patients had to be diagnosed with HF in accordance with the European Society of Cardiology diagnostic criteria, have at least one recent acute decompensation of HF requiring intravenous diuretic therapy (either hospitalized or in the day-care hospital), and be in stable condition at the time of study entry.…”

Section: Methodsmentioning

confidence: 99%

Soluble Transferrin Receptor as Iron Deficiency Biomarker: Impact on Exercise Capacity in Heart Failure Patients

Ras-Jiménez,

Ramos-Polo,

Francesch Manzano

et al. 2023

JPM

Self Cite

View full text Add to dashboard Cite

The soluble transferrin receptor (sTfR) is a marker of tissue iron status, which could indicate an increased iron demand at the tissue level. The impact of sTfR levels on functional capacity and quality of life (QoL) in non-anemic heart failure (HF) patients with otherwise normal systemic iron status has not been evaluated. We conducted an observational, prospective, cohort study of 1236 patients with chronic HF. We selected patients with normal hemoglobin levels and normal systemic iron status. Tissue iron deficiency (ID) was defined as levels of sTfR > 75th percentile (1.63 mg per L). The primary endpoints were the distance walked in the 6 min walking test (6MWT) and the overall summary score (OSS) of the Minnesota Living with Heart Failure Questionnaire (MLHFQ). The final study cohort consisted of 215 patients. Overall QoL was significantly worse (51 ± 27 vs. 39 ± 20, p-value = 0.006, respectively), and the 6 MWT distance was significantly worse in patients with tissue ID when compared to patients without tissue ID (206 ± 179 m vs. 314 ± 155, p-value < 0.0001, respectively). Higher sTfR levels, indicating increased iron demand, were associated with a shorter distance in the 6 MWT (standardized β = −0.249, p < 0.001) and a higher MLHFQ OSS (standardized β = 0.183, p-value = 0.008). In this study, we show that in patients with normal systemic iron parameters, higher levels of sTfR are strongly associated with an impaired submaximal exercise capacity and with worse QoL.

show abstract

Section: Methodsmentioning

confidence: 99%

Soluble Transferrin Receptor as Iron Deficiency Biomarker: Impact on Exercise Capacity in Heart Failure Patients

Ras-Jiménez,

Ramos-Polo,

Francesch Manzano

et al. 2023

JPM

Self Cite

View full text Add to dashboard Cite

show abstract

“…Chronic heart failure (CHF) is a complex syndrome, causing signs and symptoms such as dyspnoea, oedema, and fatigue 1 . Although advances in treatment options over the last few decades have led to improvements in its prognosis 2 , CHF, with a prevalence of over 10% among individuals aged >70 years, continues to have significant negative impact in terms of mortality, morbidity, and health-related quality of life 3 , 4 .…”

Section: Introductionmentioning

confidence: 99%

Development of a scale to gain insight into the experience of living with chronic heart failure: The UNAV-Experience of Living with Chronic Heart Failure Scale

Saracíbar-Razquin,

Zaragoza-Salcedo,

Martín-Martín

et al. 2024

An Sist Sanit Navar

View full text Add to dashboard Cite

Background: To date, there are no tools for the nursing staff to gain systematic insight on the experience lived by patients with chronic heart failure. The objective of this study was to develop a scale for this purpose. Methods: The study was conducted between January 2018 and December 2020 in three Spanish hospitals. The process described by DeVellis was used for the development of the scale. The items were built based on a phenomenological study and a systematic review of the literature. Next, feedback from a panel of experts was obtained, the scale was administered to a sample of patients with chronic heart failure, and a cognitive interview and an observational study were conducted to create the final version of the scale. Results: The first version of the scale had in seven domains and 76 items. After its evaluation by a panel of experts, it was reduced to a second version with six domains and 55 items. Following the administration of Version 2 to 17 patients (58.8% male, mean age 59.53, 70.6% classified as NYHA functional class II), five items were modified and two eliminated. Thus, the third version of the UNAV-CHF Experience Scale was composed of six domains and 53 items. Conclusions: This study presents the development of the UNAV-experience of living with chronic heart failure scale. It is an original and novel instrument that allows systematically explore this experience. A larger-scale study is necessary to confirm the validity of our scale.

show abstract

Neuropsychiatric disorders in patients with heart failure: not to be ignored

Manolis¹,

Manolis

Melita

et al. 2022

Heart Fail Rev

View full text Add to dashboard Cite

Interplay between psychosocial and heart failure related factors may partially explain limitations in self-efficacy in patients with heart failure: Insights from a real-world cohort of 1,123 patients

Cited by 4 publications

References 37 publications

Soluble Transferrin Receptor as Iron Deficiency Biomarker: Impact on Exercise Capacity in Heart Failure Patients

Soluble Transferrin Receptor as Iron Deficiency Biomarker: Impact on Exercise Capacity in Heart Failure Patients

Development of a scale to gain insight into the experience of living with chronic heart failure: The UNAV-Experience of Living with Chronic Heart Failure Scale

Neuropsychiatric disorders in patients with heart failure: not to be ignored

Contact Info

Product

Resources

About